Armata Pharmaceuticals (ARMP) Operating Leases (2019 - 2026)
Quarterly results put Operating Leases at $26.2 million for Q1 2026, down 4.5% from a year ago — trailing twelve months through Mar 2026 was $26.2 million (down 4.5% YoY), and the annual figure for FY2025 was $26.5 million, down 4.19%.
Armata Pharmaceuticals has reported Operating Leases over the past 8 years, most recently at $26.2 million for Q1 2026.
- Operating Leases reached $26.2 million in Q1 2026 per ARMP's latest filing, down from $26.5 million in the prior quarter.
- Across five years, Operating Leases topped out at $37.2 million in Q2 2022 and bottomed at $26.2 million in Q1 2026.
- Median Operating Leases over the past 5 years was $28.2 million (2024), compared with a mean of $29.7 million.
- The largest annual shift saw Operating Leases soared 251.66% in 2022 before it fell 26.33% in 2023.
- Over 5 years, Operating Leases stood at $31.8 million in 2022, then decreased by 10.13% to $28.6 million in 2023, then decreased by 3.11% to $27.7 million in 2024, then dropped by 4.19% to $26.5 million in 2025, then decreased by 1.32% to $26.2 million in 2026.
- Business Quant data shows Operating Leases for ARMP at $26.2 million in Q1 2026, $26.5 million in Q4 2025, and $26.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.18 Mn |
| Dec 31, 2025 | 26.53 Mn |
| Sep 30, 2025 | 26.84 Mn |
| Jun 30, 2025 | 27.13 Mn |
| Mar 31, 2025 | 27.42 Mn |
| Dec 31, 2024 | 27.69 Mn |
| Sep 30, 2024 | 27.93 Mn |
| Jun 30, 2024 | 28.16 Mn |
| Mar 31, 2024 | 28.38 Mn |
| Dec 31, 2023 | 28.58 Mn |
| Sep 30, 2023 | 28.16 Mn |
| Jun 30, 2023 | 27.43 Mn |
| Mar 31, 2023 | 31.84 Mn |
| Dec 31, 2022 | 31.80 Mn |
| Sep 30, 2022 | 37.22 Mn |
| Jun 30, 2022 | 37.23 Mn |
| Mar 31, 2022 | 36.92 Mn |
| Dec 31, 2021 | 36.48 Mn |
| Sep 30, 2021 | 10.59 Mn |
| Jun 30, 2021 | 10.68 Mn |
| Mar 31, 2021 | 10.78 Mn |
| Dec 31, 2020 | 10.88 Mn |
| Sep 30, 2020 | 10.91 Mn |
| Jun 30, 2020 | 11.54 Mn |
| Mar 31, 2020 | 1.19 Mn |
| Dec 31, 2019 | 1.56 Mn |
| Sep 30, 2019 | 1.90 Mn |
| Jun 30, 2019 | 2.41 Mn |